1. Home
  2. GCTK vs NUKK Comparison

GCTK vs NUKK Comparison

Compare GCTK & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • NUKK
  • Stock Information
  • Founded
  • GCTK 2001
  • NUKK 2013
  • Country
  • GCTK United States
  • NUKK United States
  • Employees
  • GCTK N/A
  • NUKK N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • NUKK Blank Checks
  • Sector
  • GCTK Health Care
  • NUKK Finance
  • Exchange
  • GCTK Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • GCTK 7.6M
  • NUKK 6.3M
  • IPO Year
  • GCTK N/A
  • NUKK N/A
  • Fundamental
  • Price
  • GCTK $0.26
  • NUKK $1.87
  • Analyst Decision
  • GCTK
  • NUKK
  • Analyst Count
  • GCTK 0
  • NUKK 0
  • Target Price
  • GCTK N/A
  • NUKK N/A
  • AVG Volume (30 Days)
  • GCTK 696.8K
  • NUKK 830.5K
  • Earning Date
  • GCTK 11-26-2024
  • NUKK 11-29-2024
  • Dividend Yield
  • GCTK N/A
  • NUKK N/A
  • EPS Growth
  • GCTK N/A
  • NUKK N/A
  • EPS
  • GCTK N/A
  • NUKK N/A
  • Revenue
  • GCTK N/A
  • NUKK $10,752,616.00
  • Revenue This Year
  • GCTK N/A
  • NUKK N/A
  • Revenue Next Year
  • GCTK N/A
  • NUKK N/A
  • P/E Ratio
  • GCTK N/A
  • NUKK N/A
  • Revenue Growth
  • GCTK N/A
  • NUKK N/A
  • 52 Week Low
  • GCTK $0.25
  • NUKK $1.30
  • 52 Week High
  • GCTK $4.95
  • NUKK $79.03
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 21.06
  • NUKK 41.68
  • Support Level
  • GCTK $1.20
  • NUKK $2.23
  • Resistance Level
  • GCTK $1.79
  • NUKK $3.33
  • Average True Range (ATR)
  • GCTK 0.30
  • NUKK 0.48
  • MACD
  • GCTK -0.12
  • NUKK -0.05
  • Stochastic Oscillator
  • GCTK 0.85
  • NUKK 28.09

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically, the majority of its revenue is generated from the United Kingdom and the rest from the United States and Malta.

Share on Social Networks: